Montelukast with levocetrizine Vs Montelukast with fexofenadine in allergic rhinitis.
Phase 4
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2024/03/063516
- Lead Sponsor
- Rohilkhand medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients willing to participate in the study
Patients of both the genders within the age of 18 years to 60 years
All patients diagnosed with allergic rhinitis
Exclusion Criteria
Female patients during pregnancy and lactation period
Patients with hypertensive disorders,diabetes mellitus, thyroid dysfunction
Patients with nasal mass or with a history of nasal surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in TOTAL NASAL SYMPTOM SCORETimepoint: 0, 2, and 4 week
- Secondary Outcome Measures
Name Time Method improvement in quality of life, side effectsTimepoint: 0, 2, and 4 week